Atabecestat
Atabecestat (JNJ-54861911) is a potent, brain-penetrant, and orally active β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor that achieves robust and high CSF Aβ reduction, is well-tolerated, and displays sustained pharmacokinetic (PK) and pharmacodynamic (PD) characteristics. Atabecestat (JNJ-54861911) has the potential for Alzheimer's Disease treatment.
Product Specifications
CAS Number
1200493-78-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
367.4
Molecular Formula
C18H14FN5OS
Notes
Research use only, not for human use.
Receptor
BACE
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC215638L3V 200 µL
PALM2-AKAP2 (PALM2AKAP2) (NM_007203) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details 
S5368-02A-AP 200 µL
SCNN1A, ID (Alpha-NaCH, Nonvoltage-gated Sodium Channel 1 Subunit alpha, SCNEA, Epithelial Na (+) Channel Subunit alpha, Alpha-ENaC, ENaCA, Amiloride-sensitive Sodium Channel Subunit alpha, SCNN1) (AP) discontinued
Ask
View Details